Vikas Madan Thapar

Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. It focuses on therapeutic areas, such as the gynecology, cardiovascular, Vitamins, minerals and nutrients, Anti-invectives, gastrointestinal, blood related oncology/anti-neoplastics, HIV, neurology, respiratory and anti-diabetic therapeutic areas. The company offers a wide range of products and services under Formulations, Biologics and Active Pharmaceutical Ingredients. It produces pharmaceutical and biopharmaceutical products of a range of dosage forms, including oral solids, oral liquids, injectables including lipid, liposomal, lyophilized injectables, biologics, vaccines and complex APIs, including chiral molecules and cytotoxic products. Emcure Pharmaceuticals was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India.

Kitara Ofil engages in providing oil well logging and analysis. The company is headquartered in Ebene, Mauritius.

Kitara PIIN 1102 operates as an investment holding company. The company is headquartered in Ebene, Mauritius.

Kitara ASL operates as an investment fund. The company is headquartered in Ebene, Mauritius.

Kitara PIIN 1001 operates as a pooled investment fund. The company is headquartered in Ebene, Mauritius.

Kitara PIIN 1101 operates as a pooled investment fund. The company is headquartered in Port Louis, Mauritius.

Part of Emcure Pharmaceuticals Ltd., Emcure Pharmaceuticals USA, Inc. manufactures drugs and pharmaceuticals. The company is based in East Brunswick, NJ.